Published in J Invest Dermatol on June 01, 1992
Immunology of diseases associated with Malassezia species. Clin Microbiol Rev (2002) 1.57
Propionibacterium acnes Induces IL-1β secretion via the NLRP3 inflammasome in human monocytes. J Invest Dermatol (2013) 1.05
The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol (2013) 0.99
Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes. Arch Dermatol Res (2010) 0.97
Role of FGFR2-signaling in the pathogenesis of acne. Dermatoendocrinol (2009) 0.92
Impaired water barrier function in acne vulgaris. Arch Dermatol Res (1995) 0.91
Toll-like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne. BMC Dermatol (2013) 0.84
The role of neuropeptides in the multifactorial pathogenesis of acne vulgaris. Dermatoendocrinol (2009) 0.84
IL-17/Th17 pathway is activated in acne lesions. PLoS One (2014) 0.84
Not all acne is acne vulgaris. Dtsch Arztebl Int (2014) 0.81
Linking diet to acne metabolomics, inflammation, and comedogenesis: an update. Clin Cosmet Investig Dermatol (2015) 0.81
Tretinoin: A Review of Its Anti-inflammatory Properties in the Treatment of Acne. J Clin Aesthet Dermatol (2011) 0.80
Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol (2014) 0.79
IL-17: a key player in the P. acnes inflammatory cascade? J Invest Dermatol (2014) 0.78
Exploring Valrubicin's Effect on Propionibacterium Acnes-Induced Skin Inflammation in Vitro and in Vivo. Dermatol Reports (2015) 0.77
Photodynamic therapy inhibit Fibroblast Growth Factor-10 induced keratinocyte differentiation and proliferation through ROS in Fibroblast Growth Factor Receptor-2b pathway. Sci Rep (2016) 0.77
L-Ascorbyl-2-phosphate attenuates NF-κB signaling in SZ95 sebocytes without affecting IL-6 and IL-8 secretion. Arch Dermatol Res (2015) 0.75
Cutaneous lesions of the nose. Head Face Med (2010) 0.75
p38 MAP Kinase Inhibition Reduces Propionibacterium acnes-Induced Inflammation in Vitro. Dermatol Ther (Heidelb) (2015) 0.75
In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms. Infect Immun (1995) 0.75
Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol (1990) 4.03
Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18
The rate of sebum excretion in man. Br J Dermatol (1969) 2.68
Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J Antimicrob Chemother (1989) 2.62
Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol (2002) 2.34
Evaluation of the modified Alvarado score in the diagnosis of acute appendicitis: a prospective study. Ann R Coll Surg Engl (1994) 2.32
Treatment of Behcet's syndrome with phenformin and ethyloestrenol. Lancet (1969) 2.28
Evaluation of a policy of total mesorectal excision for rectal and rectosigmoid cancers. Br J Surg (1997) 2.26
Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother (1993) 2.25
Antibiotic-resistant acne: lessons from Europe. Br J Dermatol (2003) 2.22
Screening for breast cancer detects tumours at an earlier biological stage. Br J Surg (1993) 2.16
Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol (2001) 2.14
Pathogenesis of acne. Lancet (1969) 2.10
Suicide in dermatological patients. Br J Dermatol (1997) 2.07
A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother (1999) 2.04
16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother (1998) 1.94
Post-adolescent acne: a review of clinical features. Br J Dermatol (1997) 1.94
A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol (1994) 1.88
Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ (1989) 1.73
The prevalence of acne vulgaris in adolescence. Br J Dermatol (1971) 1.72
Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg (1984) 1.68
Rectal retroflexion: an essential part of lower gastrointestinal endoscopic examination. Dis Colon Rectum (2001) 1.67
Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol (1989) 1.65
Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J (1979) 1.64
Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother (1997) 1.63
Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. Br J Dermatol (1990) 1.61
Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res (1990) 1.61
Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene (1995) 1.57
Genetic control of sebum excretion and acne--a twin study. Br J Dermatol (1988) 1.47
The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study. J Pathol (1997) 1.47
Interactions between the oral contraceptive pill and antibiotics. Br J Dermatol (1990) 1.45
Prevalence of facial acne in adults. J Am Acad Dermatol (1999) 1.42
Alopecia areata treated with diphencyprone: is an allergic response necessary? Br J Dermatol (1990) 1.42
The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study. Br J Cancer (1998) 1.40
The inter-relationship between isotretinoin/acne and depression. J Eur Acad Dermatol Venereol (1999) 1.40
Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol (1996) 1.40
Fabrication and reorganization of dermal equivalents suitable for skin grafting after major cutaneous injury. Biomaterials (1990) 1.40
Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol (1989) 1.40
Acne vulgaris and malignancy. Br J Dermatol (1988) 1.38
Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol (1996) 1.35
13-cis retinoic acid and acne. Lancet (1980) 1.33
Isotretinoin for acne vulgaris--10 years later: a safe and successful treatment. Br J Dermatol (1993) 1.27
Modification of human prekeratin during epidermal differentiation. Biochem J (1981) 1.27
The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol (1998) 1.25
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25
A dose-response study of I3-cis-retinoic acid in acne vulgaris. Br J Dermatol (1983) 1.23
Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990. J Am Acad Dermatol (1991) 1.22
Interaction of Propionibacterium acnes with skin lipids in vitro. J Gen Microbiol (1993) 1.20
Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol (1969) 1.19
The assessment of acne vulgaris--the Leeds technique. Br J Dermatol (1984) 1.18
Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran. Br J Dermatol (1969) 1.17
Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev (2003) 1.16
Hereditary gingival fibromatosis. Br Med J (1969) 1.16
Properties of gastric and duodenal mucus: effect of proteolysis, disulfide reduction, bile, acid, ethanol, and hypertonicity on mucus gel structure. Gastroenterology (1985) 1.15
Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol (2001) 1.15
The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ. Br J Dermatol (2000) 1.14
Sebum excretion in acromegaly. Br Med J (1972) 1.13
Identification of large cell undifferentiated tumours in lymph nodes using leucocyte common and keratin antibodies. Histopathology (1984) 1.13
Acne and unemployment. Br J Dermatol (1986) 1.12
Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. Gene (1996) 1.12
Generalized hyperhidrosis following epilepsy. Br J Dermatol (1971) 1.08
Tetracycline and acne vulgaris: a clinical and laboratory investigation. Br Med J (1973) 1.07
Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol (1990) 1.07
The effect of trimethoprim-sulphamethoxazole on sebum excretion rate and biochemistry in acne vulgaris. Br J Dermatol (1971) 1.07
Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol (1994) 1.07
Age and sex variation in skin surface lipid composition and sebum excretion rate. Br J Dermatol (1972) 1.07
Acne, hormones, and treatment. Br Med J (Clin Res Ed) (1982) 1.06
The microbial ecology of pilosebaceous units isolated from human skin. J Gen Microbiol (1984) 1.05
A histological and immunocytochemical study of early acne lesions. Br J Dermatol (1988) 1.05
Prophylactic metronidazole with and without cefuroxime in elective colorectal surgery. A prospective randomised double-blind study. J R Coll Surg Edinb (1985) 1.05
The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol (1999) 1.04
Treatment of acne with intermittent isotretinoin. Br J Dermatol (1997) 1.03
Phototherapy and acne vulgaris. Br J Dermatol (2000) 1.03
Acne vulgaris: an investigation into the number of anaerobic diphtheroids and members of the Micrococcaceae in normal and acne skin. Br J Dermatol (1977) 1.02
Purification and partial characterization of an acid phosphatase (EC 3.1.3.2) produced by Propionibacterium acnes. J Gen Microbiol (1980) 1.01
Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol (1992) 1.01
Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ (1993) 1.01
Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother (1996) 1.00